In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

The CFPB is facing pushback from the U.S. Senate over two final rules issued under the Biden administration: one expanding oversight of nonbank digital payment providers and another limiting the ...